Can a simple video ease the fear of breast cancer surgery?
NCT ID NCT05350527
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study investigates whether giving patients personalized, secure access to a web platform with an explanatory video about their upcoming breast cancer surgery can lower their anxiety. Participants are women with breast cancer scheduled for lumpectomy, oncoplasty, or mastectomy. The platform provides round-the-clock access to practical information and a surgery explanation video, aiming to reduce preoperative anxiety compared to standard information alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- personalized web platform with explanatory video
- What this could lead to
- If effective, this approach could offer a simple, low-cost way to ease anxiety for people awaiting breast cancer surgery.
- What could go wrong
- This is a small, early-stage study, so results may not apply broadly. The platform may not significantly reduce anxiety compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
89 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Histologically confirmed breast cancer. * Indication of breast lumpectomy, oncoplasty or mastectomy. * Person over 18 years old Exclusion Criteria: * Person with a history of breast cancer surgery. * Person with severely impaired physical and/or psychological health, which, in the opinion of the investigator, may affect the participant's compliance to the study. * Individuals who have difficulty understanding the French language orally. * Person who does not have Internet access at home or at work. * Person placed under court protection. * Person who is not a member or beneficiary of a national health insurance system. * Person who has not given oral informed consent after a reflection period. * Person participating in another research study with an exclusion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Béziers
Béziers, France
-
CHU de Montpellier
Montpellier, 34295, France
-
CHU de Nîmes
Nîmes, 30029, France
-
Clinique de Clémentville
Montpellier, 34000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?